Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-02-09T16:04:44.388Z Has data issue: false hasContentIssue false

Designer functionalised self-assembling peptide nanofibre scaffolds for cartilage tissue engineering

Published online by Cambridge University Press:  04 August 2014

Bin He
Affiliation:
Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Xiao Yuan
Affiliation:
Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Aiguo Zhou
Affiliation:
Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Hua Zhang
Affiliation:
Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Dianming Jiang*
Affiliation:
Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
*
*Corresponding author:D. Jiang, No. 1 Yi Xue Yuan Road, Yuzhong District, Chongqing, 400016, China. Tel: 008689011212; Fax: 008689011212; E-mail: jdm571026@vip.163.com
Rights & Permissions [Opens in a new window]

Abstract

Owing to the limited regenerative capacity of cartilage tissue, cartilage repair remains a challenge in clinical treatment. Tissue engineering has emerged as a promising and important approach to repair cartilage defects. It is well known that material scaffolds are regarded as a fundamental element of tissue engineering. Novel biomaterial scaffolds formed by self-assembling peptides consist of nanofibre networks highly resembling natural extracellular matrices, and their fabrication is based on the principle of molecular self-assembly. Indeed, peptide nanofibre scaffolds have obtained much progress in repairing various damaged tissues (e.g. cartilage, bone, nerve, heart and blood vessel). This review outlines the rational design of peptide nanofibre scaffolds and their potential in cartilage tissue engineering.

Type
Review Article
Copyright
Copyright © Cambridge University Press 2014 

Introduction

Cartilage is a resilient load-bearing tissue and provides a smooth surface with low friction that can withstand and distribute high tensile stresses (Ref. Reference Hendriks, Riesle and van Blitterswijk1). Articular cartilage has the capability to increase joint congruence, protect the subchondral bone from high stresses and reduce friction at the edge of long bones (Refs Reference Mano and Reis2, Reference Swieszkowski3). Cartilage defects have become increasingly ubiquitous in clinical medicine, and they are mainly caused by trauma, tumour removal, osteoarthritis (OA) and rheumatoid arthritis (Refs Reference Reddi, Becerra and Andrades4, Reference Bovee5, Reference Cully6, Reference Block7, Reference Firestein8). For instance, patients with OA suffer from worsening pain, tenderness and mobility because of the progressive degeneration of the joint. OA can eventually lead to full-thickness focal chondral defects and represents a huge socioeconomic burden to the society (Refs Reference Benders9, Reference Chung and Burdick10). However, cartilage tissues have very limited regenerative ability because of the lack of vascular networks, low cellularity and proliferation rate of chondrocytes, as well as the formation of protease inhibitors and growth inhibitor (Refs Reference Ouzzine, Venkatesan and Fournel-Gigleux11, Reference Ateshian12, Reference Temenoff and Mikos13). Natural repair of full-thickness cartilage defects results in fibrocartilage formation with function and mechanical force inferior to the original hyaline cartilage, and further deterioration can occur (Refs Reference Benders9, Reference Chung and Burdick10, Reference Ochi14). Although many clinical treatments have been developed for cartilage repair, there are still lack of effective treatments and the long-term prognosis is not good (Refs Reference Benders9, Reference Panseri15, Reference Gomoll16, Reference Handorf and Li17).

Tissue engineering has emerged as an interdisciplinary field merged by life sciences, physical sciences and engineering, and holds great promise in repairing various tissues or organs (Refs Reference He, Xiao and Jiang18, Reference Lutolf and Hubbell19, Reference Place, Evans and Stevens20, Reference Hosseinkhani, Hosseinkhani and Kobayashi21). It is well known that tissue engineering has the ability not only to rebuild the structure of damaged tissues, but also to recover their biological functions (Refs Reference Freed22, Reference Dvir23, Reference Tuan24). Enormous studies have demonstrated the capability of tissue engineering in repairing damaged tissues or organs (e.g. cartilage (Refs Reference Benders9, Reference Ebihara25), bone (Refs Reference Benders9, Reference Kokemueller26, Reference Hosseinkhani27), nerve (Refs Reference He, Xiao and Jiang18, Reference Kehoe, Zhang and Boyd28), heart (Refs Reference Segers and Lee29, Reference Dolgin30) and bladder (Refs Reference Drewa, Adamowicz and Sharma31, Reference Kropp and Zwischenberger32)). Material scaffold is considered to be one of the important and key elements of cartilage tissue engineering (Ref. Reference Benders9). Peptide nanofibre scaffolds are regarded as an ideal candidate material for enhancing cartilage regeneration (Refs Reference Kopesky33, Reference Kisiday34, Reference Shah35). Their fabrication is based on the principle of molecular self-assembly, which relies on chemical complementarity and structural compatibility (Refs Reference He, Xiao and Jiang18, Reference Zhang36). Peptide self-assembly into supramolecular architectures are supported by numerous non-covalent intermolecular interactions (e.g. hydrogen bonds, ionic interactions, electrostatic interactions, hydrophobic interactions, van der Waals forces and water-mediated hydrogen bonds) (Refs Reference Zhang36, Reference Loo, Zhang and Hauser37). Although these intermolecular interactions are relatively weak in isolation, collectively they can exert strong molecular forces to initiate peptide self-assembly and improve the stability of supramolecular structures (Refs Reference Zhang36, Reference Zhao and Zhang38, Reference Hartgerink, Beniash and Stupp39, Reference Hosseinkhani, Hong and Yu40).

There have been many peptides used to construct three-dimensional (3D) biomaterial scaffolds and they are grossly divided into three categories (i.e. β-sheet peptides, α-helical peptides and collagen-mimetic peptides) (Refs Reference He, Xiao and Jiang18, Reference Hosseinkhani, Hong and Yu40, Reference Cui, Webber and Stupp41, Reference Matson and Stupp42). It is widely accepted that β-sheet peptides play a dominant role in the design and fabrication of peptide-based biomaterials (Refs Reference He, Xiao and Jiang18, Reference Cui, Webber and Stupp41, Reference Stephanopoulos, Ortony and Stupp43). They include ionic self-complementary peptides (Refs Reference Zhang44, Reference Gelain, Horii and Zhang45), peptide amphiphile (PA) (Refs Reference Hartgerink, Beniash and Stupp39, Reference Hartgerink, Beniash and Stupp46, Reference Hosseinkhani47), self-assembling β-hairpins peptides (Refs Reference Schneider48, Reference Pochan49), β-sheet tapes (Refs Reference Collier and Messersmith50, Reference Jung51), ABA-block copolymer (Refs Reference Dong52, Reference Aulisa, Dong and Hartgerink53), various dipeptide and fluorenylmethoxycarbonyl (Fmoc)-conjugates (Refs Reference Zhao, Ma and Xu54, Reference Gazit55, Reference Ulijn and Smith56). Modification with peptide epitopes (i.e. functional motifs) and controlled release of molecular signals (e.g. growth factors, cytokines and chemokines) are capable to increase the similarity of peptide nanostructures to natural extracellular matrices (ECMs), and to significantly improve the bioactivity of peptide nanofibre scaffolds for cell function and tissue regeneration (Refs Reference He, Xiao and Jiang18, Reference Cui, Webber and Stupp41).

In the β-sheet system, self-assembly peptides have been extensively developed to form β-sheet secondary structure and 3D nanofibre scaffolds for various biomedical applications (Refs Reference Matson and Stupp42, Reference Gelain, Horii and Zhang45, Reference Hosseinkhani, Kobayashi and Tabata57, Reference Hosseinkhani, Hosseinkhani and Khademhosseini58). For instance, RADA16-I peptide nanofibre scaffolds are able to facilitate neurite outgrowth, heart and bone regeneration as well as wound healing (Refs Reference Holmes59, Reference Schneider, Garlick and Egles60, Reference Guo61, Reference Yoshimi62), whereas nanofibre scaffolds derived from KLDL12 peptides are beneficial to chondrocyte culture and cartilage regeneration (Refs Reference Kisiday63, Reference Liu64). IKVAV-PA hydrogels have the capability to inhibit nerve scar formation, and promote robust regeneration of nerve fibres (Refs Reference Tysseling-Mattiace65, Reference Okada66). Furthermore, peptide scaffolds formed by rP11–4 peptides and Fmoc-RGD peptides can augment the cell function of dermal fibroblasts (Refs Reference Kyle67, Reference Zhou68). This review will highlight the potential of peptide nanofibre scaffolds in cartilage tissue engineering.

Clinical treatments for cartilage repair

There have been many important treatments for cartilage defects, and they include debridement (Refs Reference Jackson and Dieterichs69, Reference Shannon70), cell-based therapies such as autologous chondrocyte implantation (ACI) (Refs Reference Kon71, Reference Marlovits72) and matrix-induced chondrocyte implantation (MACI) (Refs Reference Kon71, Reference Zheng73), replacement of the damaged tissues (e.g. by mosaicplasty (Ref. Reference Hangody74), autograft and allograft transplantation (Refs Reference Raub75, Reference Bugbee, Cavallo and Giannini76)), as well as recruitment of mesenchymal stromal cells by microfracture (Ref. Reference Steadman, Rodkey and Briggs77). Cartilage autografts are regarded as the golden standard for treating cartilage defects, but are limited by the shortage of donor grafts and the donor site morbidity (Refs Reference Clair, Johnson and Howard78, Reference Ahmed and Hincke79). Although other treatments provide fairly acceptable clinical results, repaired cartilage tissues have mechanical property and function inferior to natural hyaline cartilage and patients with these treatments do not have a good long-term prognosis (Refs Reference Panseri15, Reference Gomoll16, Reference Ebihara25, Reference Huey, Hu and Athanasiou80, Reference Mithoefer81, Reference Dhinsa and Adesida82).

Cartilage tissue engineering has become an increasingly important approach to optimise the functional restoration of damaged tissues, and focuses on the optimal combination of material scaffolds, cells and signal molecules (Ref. Reference Vinatier83). Material scaffolds used in cartilage tissue engineering can be grossly classified into three groups: (Reference Hendriks, Riesle and van Blitterswijk1) natural materials such as collagen (Ref. Reference Chen84), gelatin (Ref. Reference Shin, Olsen and Khademhosseini85), fibrin (Ref. Reference Ahmed86), alginate (Ref. Reference Schmidt, Jeong and Kong87), agarose (Ref. Reference Bougault88), chitosan (Ref. Reference Jayakumar89) and hyaluronan (Ref. Reference Chen90); (Reference Mano and Reis2) synthetic materials such as polylactic acid (PLA) (Ref. Reference Oshima91), poly(glycolic acid) (PGA) (Ref. Reference Mano and Reis2), poly(lactic-co-glycolic) acid (PLGA) (Ref. Reference Nair and Laurencin92) and polycaprolactone (PCL) (Ref. Reference Jeong, Zhang and Hollister93); as well as (Reference Swieszkowski3) their composites such as PGA/fibrin (Ref. Reference Endres94), collagen type II and RGD peptide-modified PLA/PLGA (Ref. Reference Hsu95). Natural materials have good biocompatibility and biodegradation and are able to mimic certain aspects of native ECMs. They have favourable influence on cell functions (e.g. cell proliferation, migration and differentiation) and ECMs formation (Ref. Reference Lee and Shin96). However, these materials are limited by immunogenecity, difficulty in processing, pathogens transmission and relatively weak mechanical force (Ref. Reference Panseri15, Reference Lee and Shin96). Synthetic materials have the advantage of relatively easy production as well as the ability to control dissolution and degradation (Ref. Reference Capito and Spector97). However, these synthetic materials have relatively low bioactivity for cell function and tissue regeneration. Meanwhile, they may elicit inflammatory responses (Ref. Reference Getgood98). Thus, there is a great need to develop novel material scaffolds for cartilage tissue engineering.

Peptide-based biomaterials

Peptides are regarded as versatile building blocks for fabricating supramolecular architectures, and peptide-adopted secondary structures (e.g. β-sheet, α-helix and collagen-like triple helix) contribute favourably to the design and fabrication of self-assembling biomaterials with hierarchical 3D macromolecular architectures (e.g. synthetic membranes, multilamellar structures, amphiphilic micelles, tubules and fibrillar networks), nanoscale features and tunable physical properties (Refs Reference He, Xiao and Jiang18, Reference Zhang36, Reference Loo, Zhang and Hauser37, Reference Hosseinkhani, Hong and Yu40, Reference Hartgerink, Zubarev and Stupp99). Peptide self-assembly is highly specific and the stability of peptide structures is reinforced by enormous noncovalent intermolecular interactions (Refs Reference He, Xiao and Jiang18, Reference Zhang36). The interactions between adjacent peptides can be manipulated through engineering the amino acid sequences and secondary structures of peptides (Refs Reference Loo, Zhang and Hauser37, Reference Zhao and Zhang38). Chemical design versatility of peptides and specific secondary structures provide the feasibility to tailor the structural features of peptide scaffolds (Refs Reference Zhang36, Reference Zhao and Zhang38, Reference Cui, Webber and Stupp41). This review would focus on β-sheet peptides-formed nanofibre scaffolds that have showed extraordinary ability to promote cartilage regeneration.

Ionic self-complementary peptides

In the early 1990s, a natural protein motif Zuotin in a yeast protein was serendipitously found to have the ability to form nanofibres and 3D nanostructure (Ref. Reference Zhang44). It is the first member of ionic self-complementary peptides and has the peptide sequence AEAEAKAKAEAEAKAK (i.e. EAK16-II) (Refs Reference Zhang44, Reference Yanlian100). Ionic self-complementary peptides are comprised of periodic repeats of hydrophobic sides (e.g. alanine, valine, leucine, isoleucine and phenylalanine) and hydrophilic sides such as positively charged amino acid (e.g. lysine, arginine and histidine) and negatively charged amino acids (e.g. aspartic acids and glutamic acids) (Refs Reference He, Xiao and Jiang18, Reference Zhang36, Reference Yanlian100). The complementary ionic sides are categorized into several moduli (e.g. modulus I, II, III, IV and mixed moduli: modulus I, − + − + − + − +; modulus II, − − + + − − + +; modulus III, − − − + + +; and modulus IV, − − − − + + + +) based on the hydrophilic surfaces of the molecules (Refs Reference Zhang36, Reference Yanlian100, Reference Hauser and Zhang101). In addition, the design of charge orientation in reverse orientations can produce entirely different molecules with distinct molecular behaviours (Refs Reference Zhang36, Reference Zhao and Zhang38). There have been many ionic self-complementary peptides that are under extensive studies (Table 1) (Refs Reference Zhang102, Reference Caplan103, Reference Chen104, Reference Luo, Zhao and Zhang105). During peptide self-assembly, the hydrophobic charged amino acids yield overlapping hydrophobic interactions, whereas positive and negative charges of adjacent peptides pack together through intermolecular ionic interactions in a checkerboard-like manner (Refs Reference Yanlian100, Reference Yokoi, Kinoshita and Zhang106). Assembling environment (e.g. ion strength, temperature, pH of the solution and denaturing agents) is found to have no significant influence on ionic self-complementary peptides-formed nanostructures (Refs Reference Luo, Zhao and Zhang105, Reference Gelain, Horii and Zhang107, Reference Luo, Wang and Zhang108). For instance, after the incubation of d-EAK16 peptides at 100°C for 4 h, the secondary structures of peptides have the propensity to undergo a transition from β-sheet to α-helix, indicating that β-sheet structure is unstable when meeting dramatically temperature change. After continuous incubation for 2 days, almost all peptides can form nanofibres (Fig. 1a) (Ref. Reference Luo, Zhao and Zhang105). In the solution with pH value ranging from 3.7 to 10.6, β-sheet structures formed by d-EAK16 peptides are relatively stable, and only in the solution with pH value below 1.0 and above 12.8, their stability can be reduced (Fig. 1b) (Ref. Reference Luo, Zhao and Zhang105). Some denaturing agents (e.g. 1% SDS, 8.1 m urea and 7.1 m Guanidine.HCl) are used as an interference to peptide self-assembly, but no notable changes of d-EAK16 peptide-formed structures are observed from atomic force microscopy (AFM) images (Fig. 1c) (Ref. Reference Luo, Zhao and Zhang105). Although many factors (e.g. peptide sequences, secondary structures, assembling environment and assembly kinetics) have been identified to have some impact on peptide self-assembly, the detailed mechanisms mediating peptide self-assembly into nanofibre scaffolds are still not clear (Refs Reference He, Xiao and Jiang18, Reference Zhang36, Reference Loo, Zhang and Hauser37, Reference Hosseinkhani, Hong and Yu40, Reference Yokoi, Kinoshita and Zhang106). Additionally, it is found that proteases can degrade l-form peptide bonds but cannot degrade d-form peptide bonds, suggesting that d-amino acids may contribute to the better stability of peptide bonds than l-amino acids (Refs Reference Zhang44, Reference Luo, Zhao and Zhang105). Nanofibre scaffolds formed by d-form peptide or even the combination of l-form and d-form peptides are likely to have some special biomedical applications (Ref. Reference He, Xiao and Jiang18).

Figure 1. AFM images of d-EAK16 peptide nanofibres in different assembling environment: (a) d-EAK16 peptide solution is incubated at 25°C for 4 h and then PBS is added for self-assembling overnight (left). d-EAK16 peptide solution is incubated at 100°C for 4 h and PBS is added for self-assembling overnight (middle). d-EAK16 peptide solution is incubated at 100°C for 4 h and PBS is added to stimulate self-assembly for two nights (right). (b) d-EAK16 peptides (100 µm) are displayed under different pH conditions. At pH 1, globular structures are formed (left). At pH 7, nanofibres are formed (middle). At pH 10.6, both globular structures and nanofibres are formed (right). (c) d-EAK16 peptides (1 mg/ml, 0.1%) are incubated with different denaturation agents: 1% SDS (left), 8.1 m urea (middle) and 7.1 m Guanidine.HCl (right) (Ref. Reference Luo, Zhao and Zhang105). Adapted and reprinted with permission from (Ref. Reference Luo, Zhao and Zhang105).

Table 1. The members of self-assembling ionic-complementary peptides (Refs Reference Zhang102, Reference Caplan103, Reference Chen104, Reference Luo, Zhao and Zhang105).

Peptide amphiphile

The chemical structure of a representative PA molecule has four key structural units including the hydrophobic domain (e.g. a long alkyl tail), a short peptide sequence capable to form intermolecular hydrogen bonding, charged amino acids for the design of pH and salt-responsive nanostructures, as well as the hydrophobic alkyl tail (e.g. peptide epitopes) for the interactions with cells or proteins (Fig. 2a) (Refs Reference Cui, Webber and Stupp41, Reference Stephanopoulos, Ortony and Stupp43, Reference Hartgerink, Beniash and Stupp46). The peptide sequences immediately adjacent to the hydrophobic segment benefit to form intermolecular hydrogen bonding (Refs Reference Hartgerink, Beniash and Stupp39, Reference Hartgerink, Beniash and Stupp46). For the assembly of PAs in water, there are three major energy contributions: hydrophobic interactions of the alkyl tails, hydrogen bonding among the middle peptide segments and electrostatic repulsions between the charged amino acids (Refs Reference Cui, Webber and Stupp41, Reference Stephanopoulos, Ortony and Stupp43). Their delicate balance determines the size, shape and interfacial curvature of final assemblies. The sheet-like structure of a group of PAs rather than the tapered shape of a single PA can be assembled together through intermolecular hydrogen bonding and subsequently form nanofibres as well as 3D biomaterial scaffolds (Refs Reference Cui, Webber and Stupp41, Reference Matson, Zha and Stupp109). Functional modification of PAs using peptide epitopes (e.g. RGD and IKVAV) is beneficial to cell behaviours (e.g. adhesion, proliferation and differentiation) (Refs Reference Matson and Stupp42, Reference Hosseinkhani110, Reference Hosseinkhani, Hosseinkhani and Kobayashi111). These nanofibre scaffolds can act as carriers for signal molecules and hydrophobic drugs crucial for cell function and tissue regeneration (Ref. Reference Cui, Webber and Stupp41).

Figure 2. Various peptides-formed nanofibre structures: (a) molecular model of an IKVAV-containing PA, their self-assembly into nanofibres, as well as scanning electron microscopy (SEM) image of IKVAV nanofibres after adding cell media (DMEM) to PA aqueous solution (Ref. Reference Cui, Webber and Stupp41). (b) Q11 peptides are stimulated to self-assemble by the addition of salts, pH change, or the passage of time, and consequently they result in self-assembled matrix. Quick-freeze deep etch (QFDE) TEM images shows that Q11 peptides are assembled into a highly entangled network with fibrils of ~20 nm in diameter and ~100 nm between entanglement points (Ref. Reference Collier and Messersmith50). (c) Chemical structure Fmoc-FF dipeptide and Cryo-SEM image of Fmoc-FF/K (1:1) nanofibrous hydrogel (Ref. Reference Jayawarna113). Adapted and reprinted with permission from (Refs Reference Cui, Webber and Stupp41, Reference Collier and Messersmith50, Reference Jayawarna113).

Other β-sheet peptides

In one of the β-sheet tapes, Q11 peptides are found to have the ability to form nanofibre hydrogels (Fig. 2b) (Ref. Reference Collier and Messersmith50). They can also be modified with peptide epitopes that are beneficial to cell differentiation and attachment (Ref. Reference Jung112). Dipeptides modified with an N-terminal Fmoc moiety are developed to form nanofibres and hydrogels. Hydrophobic interaction, π–π stacking effects and intermolecular β-sheet hydrogen bonds facilitate the supramolecular association and substantially improve structural stability (Ref. Reference Zhao, Ma and Xu54). For instance, fluorenylmethoxycarbonyl-diphenylalanine (Fmoc-FF) can yield stable hydrogels in physiological condition and show extraordinary cytocompatibility with chondrocytes. Combining Fmoc-FF dipeptide with Fmoc-modified amino acids (e.g. lysine, glutamic acid, arginine and serine) is intended to optimise gel stiffness and possibly increase bioactivity (Fig. 2c) (Ref. Reference Jayawarna113). In the β-sheet system, there also have been other peptide-based nanofibre scaffolds derived from self-assembling β-hairpins peptides and ABA-block copolymer (Refs Reference Schneider48, Reference Dong52).

Rational design of peptide nanofibre scaffolds resembling ECMs

Natural ECMs

Cartilage ECMs are comprised of various collagens, proteoglycans and glycosaminoglycans (GAGs) in which multiple bioactive factors (e.g. growth factors and functional peptides) are incorporated (Refs Reference Benders9, Reference Chen114). Natural tissue regeneration is mediated by highly complex temporal and spatial coordination of diverse cell–matrix and cell–cell interactions which are regulated by: (Reference Hendriks, Riesle and van Blitterswijk1) insoluble hydrated macromolecules (e.g. collagens, elastin, laminin and fibronectin), (Reference Mano and Reis2) soluble macromolecules (e.g. growth factors, chemokines and cytokines) and (Reference Swieszkowski3) proteins on the surfaces of neighbouring cells (Refs Reference Lutolf and Hubbell19, Reference Place, Evans and Stevens20, Reference Friedl115). In addition, an external stimulus (e.g. biomechanical triggers) also has an influence on the reciprocal interaction between cells and ECMs (Ref. Reference Nelson and Bissell116). The ultimate decision of cell function and ECM production is a coordinated response of cells to these ECM effectors (Ref. Reference Lutolf and Hubbell19). It is very difficult and important to manipulate the right quantity of molecular signals for corresponding cells to elicit cell function at the right time (Refs Reference Hynes117, Reference Baumann118).

Increasing the similarity to natural ECMs

Rather than directly reconstructing tissue or organs ex vivo, an emerging design philosophy for tissue engineering scaffolds is to develop smart biomaterials to induce the body's innate powers of organisation and self-repair (Ref. Reference Place, Evans and Stevens20). It is very important to obtain the symbiosis of material scaffolds, cells and signal molecules (Refs Reference He, Xiao and Jiang18, Reference Lutolf and Hubbell19). The design and fabrication of peptide nanofibre scaffolds for biomedical applications should focus on mimicking the microstructure and regulatory mechanisms of natural ECMs. The diameter of nanofibres and pore size of peptide nanofibre scaffolds are at nanometer scale (Refs Reference He, Xiao and Jiang18, Reference Cui, Webber and Stupp41, Reference Stephanopoulos, Ortony and Stupp43). For instance, ionic self-complementary peptide-formed scaffolds have nanofibres with ~10–20 nm in diameter and pore size ranging from ~5 to 200 nm (Refs Reference Dvir23, Reference Zhang36). These nanofibre networks and pore sizes are analogous to those found in natural ECMs, and they have favourable influence on cell infiltration and dwell, the delivery of oxygen and soluble signal molecules, as well as waste product removal (Refs Reference Luo, Wang and Zhang108, Reference Branco119, Reference Koutsopoulos120). Furthermore, stable hydrogels can be formed and contain extremely high water content, more than 99% in water (5–10 mg/ml, w/v) (Refs Reference Hauser and Zhang101, Reference Gelain, Horii and Zhang107).

Two significant approaches to increase the natural ECM mimicking of peptide nanofibre scaffolds are highlighted: (Reference Hendriks, Riesle and van Blitterswijk1) modification with functional motifs and (Reference Mano and Reis2) controlled release of molecular signals (Fig. 3) (Refs Reference He, Xiao and Jiang18, Reference Matson and Stupp42). There have been many functional motifs (e.g. RGD (Ref. Reference Woerly121), IKVAV (Ref. Reference Graf122) and YIGSR (Ref. Reference Jucker, Kleinman and Ingram123)) that are developed to modify biomaterial scaffolds. The tripeptide sequence RGD found in fibronectin and other ECM proteins can facilitate cell differentiation and migration through binding to α5β1 integrin receptor (Ref. Reference Ruoslahti and Pierschbacher124). One study reveals that lower RGD concentrations are found to assist in the maintenance of chondrocyte number and phenotype, as well as the increase in ECM contents compared with higher RGD concentrations (Ref. Reference Smith Callahan125). In addition, peptide PHSRNG6RGD can be fabricated through combining peptide RGD and PHSRN with the aim of increasing the similarity to functional structures of fibronectin, and result in significantly increased cell binding (Ref. Reference Potter, Kalil and Kao126). IKVAV sequences found in laminin are able to reinforce cell adhesion, migration and angiogenesis (Ref. Reference He, Xiao and Jiang18). For instance, peptide RADA16 solution and peptide RADA16–IKVAV solution are combined to form IKVAVmx hydrogel scaffolds for culturing neural stem cells, leading to substantially improved cellular proliferation, differentiation and migration when compared with pure RADA16 hydrogels (Ref. Reference Zhang127).

Figure 3. Schematic illustration of two important approaches to design self-assembling peptide nanofibre scaffolds: there have been many self-assembling peptide sequences that can be modified with functional motifs (e.g. RGD and IKVAV). These self-assembling peptides have the ability to form stable 3D nanofibre structures with functional motifs. The density of these motifs can be changed through mixing self-assembling peptides and peptides with functional motifs in different ratios. In addition, it is feasible to store, retain and release various signal molecules (e.g. growth factors) within such 3D nanofibre scaffolds. These released growth factors and functional motifs can significantly induce cell function and tissue regeneration via binding to their corresponding receptors.

In many cases, only very tiny quantities of signal molecules are required to elicit biological response, and some cellular processes demand several signalling pathways mediated by many signal molecules (Refs Reference Boontheekul and Mooney128, Reference Richardson129). Controlled release of signal molecules within peptide nanofibre scaffolds is both feasible and important to mediate cell–cell and cell–matrix interactions, and significantly promote cell function and tissue regeneration (Refs Reference Lutolf and Hubbell19, Reference Hosseinkhani, Kobayashi and Tabata57, Reference Hosseinkhani, Hosseinkhani and Khademhosseini58, Reference Hosseinkhani, Kobayashi and Tabata130, Reference Hosseinkhani131, Reference Gelain, Unsworth and Zhang132). For instance, RADA16-I peptide nanofibre scaffolds can serve as good substrates to release various functional proteins, e.g. lysozyme, trypsin inhibitor, BSA, IgG, basic-fibroblast growth factor (βFGF), vascular endothelial growth factor (VEGF) and brain-derived neurotrophic factor (BDNF), and these released functional proteins can maintain their original protein conformation and functionality based on the secondary and tertiary structure analyses and biological assays (Refs Reference Koutsopoulos120, Reference Gelain, Unsworth and Zhang132). It is found that physical hindrances can prevent proteins mobility, and interactions between proteins and nanofibres can be affected by charges (Ref. Reference Gelain, Unsworth and Zhang132). In vivo studies of animal model, the released bone morphogenetic protein 2 (BMP2) from self-assembled PA nanofibre scaffolds notably result in homogeneous ectopic bone formation in the back subcutis of rats (Ref. Reference Hosseinkhani133), while the released bFGF from PA nanofibre hydrogels leads to remarkable angiogenesis in the subcutaneous tissue of mice (Ref. Reference Hosseinkhani110). In addition, the local concentration of growth factors can be increased via the electrostatic interactions with heparan sulphate proteoglycans. There is possibility to manipulate the concentration of growth factors through modifying material scaffolds to mimic the heparan sulphate-binding groups (Refs Reference Gelain, Unsworth and Zhang132, Reference Freeman, Kedem and Cohen134). For example, modifying an alginate hydrogel through sulphating the uronic acids in the saccharide backbone can be used to mimic the heparin/heparan sulphate-binding groups. Sustained release of angiogenic and pro-survival factors within these modified hydrogels significantly increase the capability to promote pre-vascularisation of engineered cardiac patches and repair infarcted heart (Refs Reference Freeman, Kedem and Cohen134, Reference Dvir135).

Cartilage regeneration using peptide nanofibre scaffolds

Peptide nanofibre scaffolds are formed by natural amino acids, and have the properties of biological self-recognition, good biocompatibility as well as nontoxic degradation products (Ref. Reference Zhang36). Their microstructures highly mimic the natural ECM and have appropriate porosity for cell infiltration and growth (Refs Reference Zhang36, Reference Cui, Webber and Stupp41). In addition, modification with functional motifs and controlled release of molecular signals have been under extensive studies to increase the similarity of peptide nanofibre scaffolds to the microstructure and regulatory mechanisms of natural ECMs (Refs Reference He, Xiao and Jiang18, Reference Zhao and Zhang38, Reference Hosseinkhani, Hong and Yu40, Reference Cui, Webber and Stupp41). This review would focus on the capability of peptide nanofibre scaffolds to induce cartilage repair from the aspects of cell culture in vitro and tissue regeneration in vivo.

In vitro cell culture

Many peptide nanofibre scaffolds have demonstrated the ability to induce cellular activities (e.g. proliferation, differentiation, adhesion and migration) as well as ECM production by cell culture tests in vitro (Refs Reference Kisiday63, Reference Liu64, Reference Jayawarna113). FEFEFKFK peptides-formed nanofibre scaffolds are used to culture chondrocytes, resulting in good cellular viability and proliferation, cell morphology retention as well as type II collagen deposition (Fig. 4a–c) (Ref. Reference Mujeeb136). Likewise, nanofibre scaffolds derived from KLDL12 and RADA16-I peptides are beneficial to culture chondrocytes and the formation of cartilage-like ECMs enriched in GAG, proteoglycans and type II collagen (Refs Reference Kisiday63, Reference Liu64). Bone marrow stromal cells (BMSCs) cultured in RAD16-I peptide hydrogels lead to the formation of sulphated GAG, type II and type I collagens (Fig. 4d–f) (Ref. Reference Kopesky33). In addition, Fmoc-FF/S and Fmoc-FF/D hydrogels can be used to culture bovine chondrocytes, demonstrating good cell function and morphology retention (Ref. Reference Jayawarna113).

Controlled release of growth factors has been widely used for cell culture within peptide nanofibre scaffolds. For instance, KLDL12 peptide hydrogels can serve as the substrate to incorporate and release transforming growth factor β1 (TGF-β1). At day 21, cumulative release of TGF-β1 from peptide hydrogels is 32–44% as opposed to 62% of released TGF-β1 from peptide hydrogels with encapsulated BMSCs, and it is possibly associated with cell-mediated TGF-β1 degradation. Sustained release of TGF-β1 is revealed to stimulate chondrogenesis of young equine BMSCs (Ref. Reference Kopesky137). Furthermore, KLDL12 peptide hydrogels are used to seed bone marrow mesenchymal stem cells (BM-MSCs) and the released TGF-β1 from peptide hydrogels can significantly increase cell function, as well as the synthesis of proteoglycan and type II collagen (Fig. 4g and h) (Ref. Reference Kisiday34). Additionally, it is well known that dexamethasone (Dex) has pro-anabolic and anticatabolic effects on cartilage tissue engineering. However, in one study, RADA16 peptide hydrogels comprising TGF-β1 and Dex are utilised to culture young bovine and adult human BMSCs. The results demonstrate that the released Dex has the capability to reduce aggrecanase activity within peptide hydrogels for both young bovine and adult human BMSCs (Ref. Reference Florine138).

Figure 4. Promotion to cell culture in vitro: chondrocytes seeded on FEFEFKFK peptide nanofiber scaffolds contribute to good cell viability as demonstrated by (a) confocal microscopy z-stack image viewed along the z-axis (viable cells in green and the nuclei of dead cells in red) and cell morphology retention as demonstrated by (b) optical microscopy image showing the classic rounded morphology of chondrocytes in the gel matrix after 25 days culture and by (c) environmental scanning electron microscopy (ESEM) micrograph displaying a single-cell attached to the gel (Ref. Reference Mujeeb136). BMSCs cultured in RAD16-I peptide scaffolds result in extensive ECM production, as evidenced by (d) toluidine blue staining for sulphated GAG, immunohistochemistry images of (e) collagen type II and (f) type I (Ref. Reference Kopesky33). Sustained release of TGF-β1 from KLDL12 peptide hydrogels comprising BM-MSCs is beneficial to the extensive accumulation of (g) proteoglycan identified by toluidine blue staining and (h) type II collagen identified by immunohistochemical staining (Ref. Reference Kisiday34). (i) Chondrocyte-seeded KLDL12 peptide hydrogels substantially facilitate proteoglycan synthesis as showed by toluidine blue staining after 39 days of alternate day dynamic compression (Ref. Reference Kisiday144). Adapted and reprinted with permission from (Refs Reference Kopesky33, Reference Kisiday34, Reference Mujeeb136, Reference Kisiday144).

Various types of cells have been studied to serve as cell source and result in different ECM production within peptide nanofibre scaffolds. BMSCs-incorporated KLDL12 peptide hydrogels lead to form cartilage-like neotissue with longer core protein and chondroitin sulphate chains, as well as higher mechanical stiffness than that produced by chondrocytes (Ref. Reference Kopesky139). Compared to MSCs as a cell source, chondrocytes can produce ECMs with superior mechanical properties when using RADA16-I peptide hydrogels for cell culture (Ref. Reference Erickson140). In addition, for identifying the influence of GAG on chondrogenic differentiation, sulphonate, carboxylate and hydroxyl groups are incorporated on self-assembled peptide nanofibres. These functional peptide nanofibre scaffolds contribute favourably to rapid aggregation of TDC5 cells in the insulin-free medium, cartilage-like nodules formation, sulphated GAGs deposition, as well as significant gene expressions of type II collagen and aggrecan indicative of chondrogenic differentiation (Ref. Reference Ustun141).

Culturing mouse embryonic fibroblasts (MEFs) within peptide nanofibre hydrogels is affected by different elastic modulus values. At low elastic modulus values (approximately 0.1 kPa), both chondrogenic inductor BMP4 and its antagonist Noggin are detected, while at higher elastic modulus values (approximately 5 kPa), Noggin rather than BMP4 is detected, resulting in the inhibition of chondrogenesis. This study reveals that mechanical stimulus has important influence on cell function (Ref. Reference Fernandez-Muinos142). In another study, human dermal fibroblasts are cultured within self-assembling peptide hydrogels with standard chondrogenic medium. During the first day of culture, the 3D constructs undergoes a substantial contraction process and consequently form a small compact structure, resulting in a chondrocyte-like construct based on the elevated expression of GAG, proteoglycan aggrecan and type II collagen (Ref. Reference Bussmann143). Furthermore, dynamic compression is found to significantly increase proteoglycan synthesis within chondrocyte-seeded KLDL12 peptide hydrogels (Fig. 4i) (Ref. Reference Kisiday144). It is very important to control mechanical stimulus for chondrogenesis and ECM production, and much effort is needed to elucidate the mechanisms regarding the influence of mechanical stimulus on chondrogenesis.

In vivo tissue regeneration

Controlled release of growth factors from peptide nanofibre scaffolds has been used in vivo experiments. RADA16-I peptide hydrogels containing chondrocytes and TGF-β3 are transplanted into the cartilage defects of bovine model, resulting in extensive synthesis of GAG and type-II collagen, as well as good integration with native cartilage tissue and the formation of mechanically stable interface (Fig. 5a and b) (Ref. Reference Maher145). Chondrogenic factors (i.e. TGF-β1, insulin-like growth factor-1 (IGF-1) and Dex) are combined with KLDL12 peptide hydrogels to treat the full-thickness and critically sized defects of rabbit cartilage, contributing to significant formation of aggrecan and type II collagen (Ref. Reference Miller146). In addition, TGF-binding PAs (TGFBPA: HSNGLPLGGGSEEEAAAVVV(K)-CO(CH2)10CH3) are designed with binding epitopes to TGF-β1 and can effectively reduce the passive release of TGF-β1. In vitro experiments reveal that these peptide scaffolds comprising TGF-β1 are capable to induce the chondrogenic differentiation of human MSCs. TGF-binding PA nanofibre scaffolds comprising TGF-β1 can substantially promote the regeneration of articular cartilage in the full-thickness chondral defects treated with microfracture in the trochlea of adult rabbits in the presence of bone marrow MSCs, indicating the importance of growth factor release and functional modification within peptide nanofibre scaffolds for cartilage repair (Fig. 5c–e) (Ref. Reference Shah35).

Figure 5. Promotion to cartilage regeneration in vivo: Alcian blue–eosin stained sections of the interface between the inner core and outer ring articular cartilage components at culture day 21, (a) RADA16-I hydrogel containing both TGF-β3 and chondrocytes showing robust cartilage formation in intimate contact with the native cartilage components compared to the treatment of (b) hydrogel-containing chondrocytes only (Ref. Reference Maher145). Articular cartilage defects after 12 weeks postop treated with 10%TGFBPA + 100 ng/ml TGF-β1 (100TGF), showed by macroscopic views (c), histological evaluation of sample sections: (d) safranin-O staining for GAGs and (e) type II collagen staining (Ref. Reference Shah35). Adapted and reprinted with permission from (Refs Reference Shah35, Reference Maher145).

Conclusion and future prospective

Self-assembling peptide nanofibre scaffolds have become increasingly important biomaterials for cartilage tissue engineering. Their nanofibre networks highly mimic natural ECMs and these similarities can be increased by modification with functional motifs and controlled release of signal molecules. However, the mechanical force of peptide nanofibre scaffolds is relatively weak and it is very difficult to use such biomaterial scaffolds to repair the defects of loading-bearing cartilages.

It is generally accepted that the design of synthetic biomaterial scaffolds should aim to resemble the microstructures and regulatory mechanisms of natural ECMs for the purpose of stimulating the best regenerative ability of damaged tissues or organs. It is very important but difficult to modulate cell behaviours (e.g. proliferation, differentiation and migration) within peptide nanofibre scaffolds because these regulatory mechanisms in natural ECMs are very complicated and hard to manipulate. The design of biomaterial scaffolds mimicking natural ECMs may significantly increase the possibility of controlling cell functions.

Acknowledgements

D.M. Jiang was supported in part by China National ‘‘973 Project’' and by the grant from the Natural Science Foundation Project of CQ CSTC (2009AB5080), and National Natural Science Foundation of China (NSFC, 81171685/H0604). We apologize to all the scientists whose work we could not cite due to space restrictions.

References

1Hendriks, J., Riesle, J. and van Blitterswijk, C.A. (2007) Co-culture in cartilage tissue engineering. Journal of Tissue Engineering and Regenerative Medicine 1, 170-178CrossRefGoogle ScholarPubMed
2Mano, J.F. and Reis, R.L. (2007) Osteochondral defects: present situation and tissue engineering approaches. Journal of Tissue Engineering and Regenerative Medicine 1, 261-273CrossRefGoogle ScholarPubMed
3Swieszkowski, W. et al. (2007) Repair and regeneration of osteochondral defects in the articular joints. Biomolecular Engineering 24, 489-495CrossRefGoogle ScholarPubMed
4Reddi, A.H., Becerra, J. and Andrades, J.A. (2011) Nanomaterials and hydrogel scaffolds for articular cartilage regeneration. Tissue Engineering Part B Reviews 17, 301-305CrossRefGoogle ScholarPubMed
5Bovee, J.V. et al. (2010) Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nature Reviews Cancer 10, 481-488CrossRefGoogle ScholarPubMed
6Cully, M. (2013) Regenerative medicine: adhesive-hydrogel composite developed to repair damaged cartilage. Nature Reviews Rheumatology 9, 135CrossRefGoogle ScholarPubMed
7Block, J.A. (2014) Osteoarthritis: OA guidelines: improving care or merely codifying practice? Nature Reviews Rheumatology 10, 324-326.CrossRefGoogle ScholarPubMed
8Firestein, G.S. (2003) Evolving concepts of rheumatoid arthritis. Nature 423, 356-361CrossRefGoogle ScholarPubMed
9Benders, K.E. et al. (2013) Extracellular matrix scaffolds for cartilage and bone regeneration. Trends in Biotechnology 31, 169-176CrossRefGoogle ScholarPubMed
10Chung, C. and Burdick, J.A. (2008) Engineering cartilage tissue. Advanced Drug Delivery Reviews 60, 243-262CrossRefGoogle ScholarPubMed
11Ouzzine, M., Venkatesan, N. and Fournel-Gigleux, S. (2012) Proteoglycans and cartilage repair. Methods in Molecular Biology 836, 339-355CrossRefGoogle ScholarPubMed
12Ateshian, G.A. (2007) Artificial cartilage: weaving in three dimensions. Nature Materials 6, 89-90CrossRefGoogle ScholarPubMed
13Temenoff, J.S. and Mikos, A.G. (2000) Review: tissue engineering for regeneration of articular cartilage. Biomaterials 21, 431-440CrossRefGoogle ScholarPubMed
14Ochi, M. et al. (2001) Current concepts in tissue engineering technique for repair of cartilage defect. Artificial Organs 25, 172-179CrossRefGoogle ScholarPubMed
15Panseri, S. et al. (2012) Osteochondral tissue engineering approaches for articular cartilage and subchondral bone regeneration. Knee Surgery Sports Traumatology Arthroscopy 20, 1182-1191CrossRefGoogle ScholarPubMed
16Gomoll, A.H. et al. (2010) The subchondral bone in articular cartilage repair: current problems in the surgical management. Knee Surgery Sports Traumatology Arthroscopy 18, 434-447CrossRefGoogle ScholarPubMed
17Handorf, A.M. and Li, W.J. (2014) Induction of mesenchymal stem cell chondrogenesis through sequential administration of growth factors within specific temporal windows. Journal of Cellular Physiology 229, 162-171CrossRefGoogle ScholarPubMed
18He, B., Xiao, Y. and Jiang, D. (2014) Molecular self-assembly guides the fabrication of peptide nanofiber scaffolds for nerve repair. RSC Advances 4, 23610-23621.CrossRefGoogle Scholar
19Lutolf, M.P. and Hubbell, J.A. (2005) Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nature Biotechnology 23, 47-55CrossRefGoogle ScholarPubMed
20Place, E.S., Evans, N.D. and Stevens, M.M. (2009) Complexity in biomaterials for tissue engineering. Nature Materials 8, 457-470CrossRefGoogle ScholarPubMed
21Hosseinkhani, H., Hosseinkhani, M. and Kobayashi, H. (2006) Design of tissue-engineered nanoscaffold through self-assembly of peptide amphiphile. Journal of Bioactive and Compatible Polymers 21, 277-296CrossRefGoogle Scholar
22Freed, L.E. et al. (2006) Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Engineering 12, 3285-3305CrossRefGoogle ScholarPubMed
23Dvir, T. et al. (2011) Nanotechnological strategies for engineering complex tissues. Nature Nanotechnology 6, 13-22CrossRefGoogle ScholarPubMed
24Tuan, R.S. (2013) Regenerative medicine in 2012: the coming of age of musculoskeletal tissue engineering. Nature Reviews Rheumatology 9, 74-76CrossRefGoogle ScholarPubMed
25Ebihara, G. et al. (2012) Cartilage repair in transplanted scaffold-free chondrocyte sheets using a minipig model. Biomaterials 33, 3846-3851CrossRefGoogle ScholarPubMed
26Kokemueller, H. et al. (2010) Prefabrication of vascularized bioartificial bone grafts in vivo for segmental mandibular reconstruction: experimental pilot study in sheep and first clinical application. International Journal of Oral and Maxillofacial Surgery 39, 379-387CrossRefGoogle ScholarPubMed
27Hosseinkhani, H. et al. (2007) Bone regeneration on a collagen sponge self-assembled peptide-amphiphile nanofiber hybrid scaffold. Tissue Engineering 13, 11-19CrossRefGoogle ScholarPubMed
28Kehoe, S., Zhang, X.F. and Boyd, D. (2012) FDA approved guidance conduits and wraps for peripheral nerve injury: a review of materials and efficacy. Injury 43, 553-572CrossRefGoogle ScholarPubMed
29Segers, V.F. and Lee, R.T. (2011) Biomaterials to enhance stem cell function in the heart. Circulation Research 109, 910-922CrossRefGoogle ScholarPubMed
30Dolgin, E. (2011) Taking tissue engineering to heart. Nature Medicine 17, 1032-1035CrossRefGoogle ScholarPubMed
31Drewa, T., Adamowicz, J. and Sharma, A. (2012) Tissue engineering for the oncologic urinary bladder. Nature Reviews Urology 9, 561-572CrossRefGoogle ScholarPubMed
32Kropp, B.P. and Zwischenberger, J.B. (2006) Tissue-engineered autologous bladders: new possibilities for cystoplasty. Nature Clinical Practice Urology 3, 588-589CrossRefGoogle ScholarPubMed
33Kopesky, P.W. et al. (2010) Self-assembling peptide hydrogels modulate in vitro chondrogenesis of bovine bone marrow stromal cells. Tissue Engineering Part A 16, 465-477CrossRefGoogle ScholarPubMed
34Kisiday, J.D. et al. (2008) Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. Journal of Orthopaedic Research 26, 322-331CrossRefGoogle ScholarPubMed
35Shah, R.N. et al. (2010) Supramolecular design of self-assembling nanofibers for cartilage regeneration. Proceedings of the National Academy of Sciences of the United States of America 107, 3293-3298CrossRefGoogle ScholarPubMed
36Zhang, S. (2003) Fabrication of novel biomaterials through molecular self-assembly. Nature Biotechnology 21, 1171-1178CrossRefGoogle ScholarPubMed
37Loo, Y., Zhang, S. and Hauser, C.A. (2012) From short peptides to nanofibers to macromolecular assemblies in biomedicine. Biotechnology Advances 30, 593-603CrossRefGoogle ScholarPubMed
38Zhao, X. and Zhang, S. (2006) Molecular designer self-assembling peptides. Chemical Society Reviews 35, 1105-1110CrossRefGoogle ScholarPubMed
39Hartgerink, J.D., Beniash, E. and Stupp, S.I. (2002) Peptide-amphiphile nanofibers: a versatile scaffold for the preparation of self-assembling materials. Proceedings of the National Academy of Sciences of the United States of America 99, 5133-5138CrossRefGoogle ScholarPubMed
40Hosseinkhani, H., Hong, P.D. and Yu, D.S. (2013) Self-assembled proteins and peptides for regenerative medicine. Chemical Reviews 113, 4837-4861CrossRefGoogle ScholarPubMed
41Cui, H., Webber, M.J. and Stupp, S.I. (2010) Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials. Biopolymers 94, 1-18CrossRefGoogle ScholarPubMed
42Matson, J.B. and Stupp, S.I. (2012) Self-assembling peptide scaffolds for regenerative medicine. Chemical Communications (Camb) 48, 26-33CrossRefGoogle ScholarPubMed
43Stephanopoulos, N., Ortony, J.H. and Stupp, S.I. (2013) Self-assembly for the synthesis of functional biomaterials. Acta Materialia 61, 912-930CrossRefGoogle ScholarPubMed
44Zhang, S. et al. (1993) Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proceedings of the National Academy of Sciences of the United States of America 90, 3334-3338CrossRefGoogle Scholar
45Gelain, F., Horii, A. and Zhang, S. (2007) Designer self-assembling peptide scaffolds for 3-D tissue cell cultures and regenerative medicine. Macromolecular Bioscience 7, 544-551CrossRefGoogle ScholarPubMed
46Hartgerink, J.D., Beniash, E. and Stupp, S.I. (2001) Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 294, 1684-1688CrossRefGoogle ScholarPubMed
47Hosseinkhani, H. et al. (2006) Ectopic bone formation in collagen sponge self-assembled peptide-amphiphile nanofibers hybrid scaffold in a perfusion culture bioreactor. Biomaterials 27, 5089-5098CrossRefGoogle Scholar
48Schneider, J.P. et al. (2002) Responsive hydrogels from the intramolecular folding and self-assembly of a designed peptide. Journal of the American Chemical Society 124, 15030-15037CrossRefGoogle ScholarPubMed
49Pochan, D.J. et al. (2003) Thermally reversible hydrogels via intramolecular folding and consequent self-assembly of a de novo designed peptide. Journal of the American Chemical Society 125, 11802-11803CrossRefGoogle ScholarPubMed
50Collier, J.H. and Messersmith, P.B. (2003) Enzymatic modification of self-assembled peptide structures with tissue transglutaminase. Bioconjugate Chemistry 14, 748-755CrossRefGoogle ScholarPubMed
51Jung, J.P., et al. (2008) Modulating the mechanical properties of self-assembled peptide hydrogels via native chemical ligation. Biomaterials 29, 2143-2151CrossRefGoogle ScholarPubMed
52Dong, H. et al. (2007) Self-assembly of multidomain peptides: balancing molecular frustration controls conformation and nanostructure. Journal of the American Chemical Society 129, 12468-12472CrossRefGoogle ScholarPubMed
53Aulisa, L., Dong, H. and Hartgerink, J.D. (2009) Self-assembly of multidomain peptides: sequence variation allows control over cross-linking and viscoelasticity. Biomacromolecules 10, 2694-2698CrossRefGoogle ScholarPubMed
54Zhao, F., Ma, M.L. and Xu, B. (2009) Molecular hydrogels of therapeutic agents. Chemical Society Reviews 38, 883-891CrossRefGoogle ScholarPubMed
55Gazit, E. (2007) Self-assembled peptide nanostructures: the design of molecular building blocks and their technological utilization. Chemical Society Reviews 36, 1263-1269CrossRefGoogle ScholarPubMed
56Ulijn, R.V. and Smith, A.M. (2008) Designing peptide based nanomaterials. Chemical Society Reviews 37, 664-675CrossRefGoogle ScholarPubMed
57Hosseinkhani, H., Kobayashi, H. and Tabata, Y. (2006) Design of tissue-engineered nano-scaffold using peptide amphiphile for regenerative medicine. Peptide Science 2005, 341-344Google Scholar
58Hosseinkhani, H., Hosseinkhani, M. and Khademhosseini, A. (2006) Tissue regeneration through self-assembled peptide amphiphile nanofibers. Yakhte Medical Journal 8, 204-209Google Scholar
59Holmes, T.C. et al. (2000) Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds. Proceedings of the National Academy of Sciences of the United States of America 97, 6728-6733CrossRefGoogle ScholarPubMed
60Schneider, A., Garlick, J.A. and Egles, C. (2008) Self-assembling peptide nanofiber scaffolds accelerate wound healing. PLoS ONE 3, e1410CrossRefGoogle ScholarPubMed
61Guo, H.D. et al. (2010) Transplantation of marrow-derived cardiac stem cells carried in designer self-assembling peptide nanofibers improves cardiac function after myocardial infarction. Biochemical and Biophysical Research Communications 399, 42-48CrossRefGoogle ScholarPubMed
62Yoshimi, R. et al. (2009) Self-assembling peptide nanofiber scaffolds, platelet-rich plasma, and mesenchymal stem cells for injectable bone regeneration with tissue engineering. Journal of Craniofacial Surgery 20, 1523-1530CrossRefGoogle ScholarPubMed
63Kisiday, J. et al. (2002) Self-assembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division: implications for cartilage tissue repair. Proceedings of the National Academy of Sciences of the United States of America 99, 9996-10001CrossRefGoogle ScholarPubMed
64Liu, J. et al. (2010) Self-assembly-peptide hydrogels as tissue-engineering scaffolds for three-dimensional culture of chondrocytes in vitro. Macromolecular Bioscience 10, 1164-1170CrossRefGoogle ScholarPubMed
65Tysseling-Mattiace, V.M. et al. (2008) Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. Journal of Neuroscience 28, 3814-3823CrossRefGoogle ScholarPubMed
66Okada, S. et al. (2006) Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nature Medicine 12, 829-834CrossRefGoogle ScholarPubMed
67Kyle, S. et al. (2010) Recombinant self-assembling peptides as biomaterials for tissue engineering. Biomaterials 31, 9395-9405CrossRefGoogle ScholarPubMed
68Zhou, M. et al. (2009) Self-assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells. Biomaterials 30, 2523-2530CrossRefGoogle ScholarPubMed
69Jackson, R.W. and Dieterichs, C. (2003) The results of arthroscopic lavage and debridement of osteoarthritic knees based on the severity of degeneration: a 4- to 6-year symptomatic follow-up. Arthroscopy 19, 13-20CrossRefGoogle ScholarPubMed
70Shannon, F.J. et al. (2001) Short-term benefit of arthroscopic washout in degenerative arthritis of the knee. International Orthopaedics 25, 242-245CrossRefGoogle ScholarPubMed
71Kon, E. et al. (2012) ACI and MACI. Journal of Knee Surgery 25, 17-22Google ScholarPubMed
72Marlovits, S. et al. (2006) Cartilage repair: generations of autologous chondrocyte transplantation. European Journal of Radiology 57, 24-31CrossRefGoogle ScholarPubMed
73Zheng, M.H. et al. (2007) Matrix-induced autologous chondrocyte implantation (MACI): biological and histological assessment. Tissue Engineering 13, 737-746CrossRefGoogle ScholarPubMed
74Hangody, L. et al. (1998) Mosaicplasty for the treatment of articular cartilage defects: application in clinical practice. Orthopedics 21, 751-756CrossRefGoogle ScholarPubMed
75Raub, C.B. et al. (2013) Microstructural remodeling of articular cartilage following defect repair by osteochondral autograft transfer. Osteoarthritis Cartilage 21, 860-868CrossRefGoogle ScholarPubMed
76Bugbee, W., Cavallo, M. and Giannini, S. (2012) Osteochondral allograft transplantation in the knee. Journal of Knee Surgery 25, 109-116Google ScholarPubMed
77Steadman, J.R., Rodkey, W.G. and Briggs, K.K. (2002) Microfracture to treat full-thickness chondral defects: surgical technique, rehabilitation, and outcomes. Journal of Knee Surgery 15, 170-176Google ScholarPubMed
78Clair, B.L., Johnson, A.R. and Howard, T. (2009) Cartilage repair: current and emerging options in treatment. Foot Ankle Specialist 2, 179-188CrossRefGoogle ScholarPubMed
79Ahmed, T.A. and Hincke, M.T. (2010) Strategies for articular cartilage lesion repair and functional restoration. Tissue Engineering Part B Reviews 16, 305-329CrossRefGoogle ScholarPubMed
80Huey, D.J., Hu, J.C. and Athanasiou, K.A. (2012) Unlike bone, cartilage regeneration remains elusive. Science 338, 917-921CrossRefGoogle ScholarPubMed
81Mithoefer, K. et al. (2009) Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis. American Journal of Sports Medicine 37, 2053-2063CrossRefGoogle ScholarPubMed
82Dhinsa, B.S. and Adesida, A.B. (2012) Current clinical therapies for cartilage repair, their limitation and the role of stem cells. Current Stem Cell Research Therapy 7, 143-148CrossRefGoogle ScholarPubMed
83Vinatier, C. et al. (2009) Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends in Biotechnology 27, 307-314CrossRefGoogle ScholarPubMed
84Chen, W.C. et al. (2011) Evaluating osteochondral defect repair potential of autologous rabbit bone marrow cells on type II collagen scaffold. Cytotechnology 63, 13-23CrossRefGoogle ScholarPubMed
85Shin, H., Olsen, B.D. and Khademhosseini, A. (2012) The mechanical properties and cytotoxicity of cell-laden double-network hydrogels based on photocrosslinkable gelatin and gellan gum biomacromolecules. Biomaterials 33, 3143-3152CrossRefGoogle ScholarPubMed
86Ahmed, T.A. et al. (2011) Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute. Tissue Engineering Part A 17, 323-335CrossRefGoogle ScholarPubMed
87Schmidt, J.J., Jeong, J. and Kong, H. (2011) The interplay between cell adhesion cues and curvature of cell adherent alginate microgels in multipotent stem cell culture. Tissue Engineering Part A 17, 2687-2694CrossRefGoogle ScholarPubMed
88Bougault, C. et al. (2012) Dynamic compression of chondrocyte-agarose constructs reveals new candidate mechanosensitive genes. PLoS ONE 7, 17CrossRefGoogle ScholarPubMed
89Jayakumar, R. et al. (2011) Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnology Advances 29, 322-337CrossRefGoogle ScholarPubMed
90Chen, C.H. et al. (2013) Hyaluronan enhances bone marrow cell therapy for myocardial repair after infarction. Molecular Therapy 21, 670-679CrossRefGoogle ScholarPubMed
91Oshima, Y. et al. (2009) Variation of mesenchymal cells in polylactic acid scaffold in an osteochondral repair model. Tissue Engineering Part C Methods 15, 595-604CrossRefGoogle Scholar
92Nair, L.S. and Laurencin, C.T. (2007) Biodegradable polymers as biomaterials. Progress in Polymer Science 32, 762-798CrossRefGoogle Scholar
93Jeong, C.G., Zhang, H. and Hollister, S.J. (2012) Three-dimensional polycaprolactone scaffold-conjugated bone morphogenetic protein-2 promotes cartilage regeneration from primary chondrocytes in vitro and in vivo without accelerated endochondral ossification. Journal of Biomedical Materials Research Part A 100, 2088-2096CrossRefGoogle ScholarPubMed
94Endres, M. et al. (2012) An ovine in vitro model for chondrocyte-based scaffold-assisted cartilage grafts. Journal of Orthopaedic Surgery and Research 7, 37CrossRefGoogle ScholarPubMed
95Hsu, S.H. et al. (2006) Evaluation of biodegradable polyesters modified by type II collagen and Arg-Gly-Asp as tissue engineering scaffolding materials for cartilage regeneration. Artificial Organs 30, 42-55CrossRefGoogle ScholarPubMed
96Lee, S.H. and Shin, H. (2007) Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Advanced Drug Delivery Reviews 59, 339-359CrossRefGoogle ScholarPubMed
97Capito, R.M. and Spector, M. (2003) Scaffold-based articular cartilage repair. IEEE Engineering in Medicine and Biology Magazine 22, 42-50CrossRefGoogle ScholarPubMed
98Getgood, A. et al. (2009) Articular cartilage tissue engineering: today's research, tomorrow's practice? Journal of Bone and Joint Surgery – British Volume 91, 565-576CrossRefGoogle ScholarPubMed
99Hartgerink, J.D., Zubarev, E.R. and Stupp, S.I. (2001) Supramolecular one-dimensional objects. Current Opinion in Solid State and Materials Science 5, 355-361CrossRefGoogle Scholar
100Yanlian, Y. et al. (2009) Designer self-assembling peptide nanomaterials. Nano Today 4, 193-210CrossRefGoogle Scholar
101Hauser, C.A. and Zhang, S. (2010) Designer self-assembling peptide nanofiber biological materials. Chemical Society Reviews 39, 2780-2790CrossRefGoogle ScholarPubMed
102Zhang, S. (2002) Emerging biological materials through molecular self-assembly. Biotechnology Advances 20, 321-339CrossRefGoogle ScholarPubMed
103Caplan, M.R. et al. (2002) Control of self-assembling oligopeptide matrix formation through systematic variation of amino acid sequence. Biomaterials 23, 219-227CrossRefGoogle ScholarPubMed
104Chen, P. (2005) Self-assembly of ionic-complementary peptides: a physicochemical viewpoint. Colloids and Surfaces A: Physicochemical and Engineering Aspects 261, 3-24CrossRefGoogle Scholar
105Luo, Z., Zhao, X. and Zhang, S. (2008) Structural dynamic of a self-assembling peptide d-EAK16 made of only D-amino acids. PLoS One 3, e2364CrossRefGoogle ScholarPubMed
106Yokoi, H., Kinoshita, T. and Zhang, S. (2005) Dynamic reassembly of peptide RADA16 nanofiber scaffold. Proceedings of the National Academy of Sciences of the United States of America 102, 8414-8419CrossRefGoogle ScholarPubMed
107Gelain, F., Horii, A. and Zhang, S. (2007) Designer self-assembling peptide scaffolds for 3-d tissue cell cultures and regenerative medicine. Macromolecular Bioscience 7, 544-551CrossRefGoogle ScholarPubMed
108Luo, Z., Wang, S. and Zhang, S. (2011) Fabrication of self-assembling D-form peptide nanofiber scaffold d-EAK16 for rapid hemostasis. Biomaterials 32, 2013-2020CrossRefGoogle ScholarPubMed
109Matson, J.B., Zha, R.H. and Stupp, S.I. (2011) Peptide self-assembly for crafting functional biological materials. Current Opinion in Solid State and Materials Science 15, 225-235CrossRefGoogle ScholarPubMed
110Hosseinkhani, H. et al. (2006) Osteogenic differentiation of mesenchymal stem cells in self-assembled peptide-amphiphile nanofibers. Biomaterials 27, 4079-4086CrossRefGoogle ScholarPubMed
111Hosseinkhani, H., Hosseinkhani, M. and Kobayashi, H. (2006) Proliferation and differentiation of mesenchymal stem cells using self-assembled peptide amphiphile nanofibers. Biomedical Materials 1, 8-15CrossRefGoogle ScholarPubMed
112Jung, J.P. et al. (2009) Co-assembling peptides as defined matrices for endothelial cells. Biomaterials 30, 2400-2410CrossRefGoogle ScholarPubMed
113Jayawarna, V. et al. (2009) Introducing chemical functionality in Fmoc-peptide gels for cell culture. Acta Biomaterialia 5, 934-943CrossRefGoogle ScholarPubMed
114Chen, J.L. et al. (2014) Extracellular matrix production in vitro in cartilage tissue engineering. Stem Cells 8, 14-15Google Scholar
115Friedl, P. et al. (2012) New dimensions in cell migration. Nature Reviews Molecular Cell Biology 13, 743-747CrossRefGoogle ScholarPubMed
116Nelson, C.M. and Bissell, M.J. (2006) Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annual Review of Cell and Developmental Biology 22, 287-309CrossRefGoogle ScholarPubMed
117Hynes, R.O. (2009) The extracellular matrix: not just pretty fibrils. Science 326, 1216-1219CrossRefGoogle Scholar
118Baumann, K. (2012) Stem cells: holding tight onto the niche. Nature Reviews Molecular Cell Biology 13, 278-279Google Scholar
119Branco, M.C. et al. (2009) Macromolecular diffusion and release from self-assembled beta-hairpin peptide hydrogels. Biomaterials 30, 1339-1347CrossRefGoogle ScholarPubMed
120Koutsopoulos, S. et al. (2009) Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold. Proceedings of the National Academy of Sciences of the United States of America 106, 4623-4628CrossRefGoogle ScholarPubMed
121Woerly, S. et al. (2001) Spinal cord repair with PHPMA hydrogel containing RGD peptides (NeuroGel). Biomaterials 22, 1095-1111CrossRefGoogle ScholarPubMed
122Graf, J. et al. (1987) A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the 67,000 laminin receptor. Biochemistry 26, 6896-6900CrossRefGoogle Scholar
123Jucker, M., Kleinman, H.K. and Ingram, D.K. (1991) Fetal rat septal cells adhere to and extend processes on basement membrane, laminin, and a synthetic peptide from the laminin A chain sequence. Journal of Neuroscience Research 28, 507-517CrossRefGoogle Scholar
124Ruoslahti, E. and Pierschbacher, M.D. (1986) Arg–Gly–Asp: a versatile cell recognition signal. Cell 44, 517-518CrossRefGoogle ScholarPubMed
125Smith Callahan, L.A. et al. (2013) Maximizing phenotype constraint and extracellular matrix production in primary human chondrocytes using arginine–glycine–aspartate concentration gradient hydrogels. Acta Biomaterialia 9, 7420-7428CrossRefGoogle ScholarPubMed
126Potter, W., Kalil, R.E. and Kao, W.J. (2008) Biomimetic material systems for neural progenitor cell-based therapy. Frontiers in Bioscience 13, 806-821CrossRefGoogle ScholarPubMed
127Zhang, Z.X. et al. (2010) Compatibility of neural stem cells with functionalized self-assembling peptide scaffold in vitro. Biotechnology and Bioengineering 15, 545-551Google Scholar
128Boontheekul, T. and Mooney, D.J. (2003) Protein-based signaling systems in tissue engineering. Current Opinion in Biotechnology 14, 559-565CrossRefGoogle ScholarPubMed
129Richardson, T.P. et al. (2001) Polymeric system for dual growth factor delivery. Nature Biotechnology 19, 1029-1034CrossRefGoogle ScholarPubMed
130Hosseinkhani, H., Kobayashi, H. and Tabata, Y. (2006) Selective differentiation of cardiomyocyte cells by using peptide amphiphile nanofibers. Peptide Science 2005, 63-66Google Scholar
131Hosseinkhani, H. et al. (2006) Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. Biomaterials 27, 5836-5844CrossRefGoogle ScholarPubMed
132Gelain, F., Unsworth, L.D. and Zhang, S. (2010) Slow and sustained release of active cytokines from self-assembling peptide scaffolds. Journal of Controlled Release 145, 231-239CrossRefGoogle ScholarPubMed
133Hosseinkhani, H. et al. (2007) Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. Journal of Controlled Release 117, 380-386CrossRefGoogle ScholarPubMed
134Freeman, I., Kedem, A. and Cohen, S. (2008) The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 29, 3260-3268CrossRefGoogle ScholarPubMed
135Dvir, T. et al. (2009) Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proceedings of the National Academy of Sciences of the United States of America 106, 14990-14995CrossRefGoogle ScholarPubMed
136Mujeeb, A. et al. (2013) Self-assembled octapeptide scaffolds for in vitro chondrocyte culture. Acta Biomaterialia 9, 4609-4617CrossRefGoogle ScholarPubMed
137Kopesky, P.W. et al. (2014) Sustained delivery of bioactive TGF-beta1 from self-assembling peptide hydrogels induces chondrogenesis of encapsulated bone marrow stromal cells. Journal of Biomedical Materials Research Part A 102, 1275-1285CrossRefGoogle ScholarPubMed
138Florine, E.M. et al. (2013) Effects of dexamethasone on mesenchymal stromal cell chondrogenesis and aggrecanase activity: comparison of agarose and self-assembling peptide scaffolds. Cartilage 4, 63-74CrossRefGoogle ScholarPubMed
139Kopesky, P.W. et al. (2010) Adult equine bone marrow stromal cells produce a cartilage-like ECM mechanically superior to animal-matched adult chondrocytes. Matrix Biology 29, 427-438CrossRefGoogle ScholarPubMed
140Erickson, I.E. et al. (2009) Differential maturation and structure-function relationships in mesenchymal stem cell- and chondrocyte-seeded hydrogels. Tissue Engineering Part A 15, 1041-1052CrossRefGoogle ScholarPubMed
141Ustun, S. et al. (2013) Growth and differentiation of prechondrogenic cells on bioactive self-assembled peptide nanofibers. Biomacromolecules 14, 17-26CrossRefGoogle ScholarPubMed
142Fernandez-Muinos, T. et al. (2014) Matrix dimensions, stiffness, and structural properties modulate spontaneous chondrogenic commitment of mouse embryonic fibroblasts. Tissue Engineering Part A 20, 1145-1155CrossRefGoogle ScholarPubMed
143Bussmann, B.M. et al. (2013) Chondrogenic potential of human dermal fibroblasts in a contractile, soft, self-assembling, peptide hydrogel. Journal of Tissue Engineering and Regenerative Medicine. Published online ahead of print, doi: 10.1002/term.1766Google Scholar
144Kisiday, J.D. et al. (2004) Effects of dynamic compressive loading on chondrocyte biosynthesis in self-assembling peptide scaffolds. Journal of Biomechanics 37, 595-604CrossRefGoogle ScholarPubMed
145Maher, S.A. et al. (2010) A nanofibrous cell-seeded hydrogel promotes integration in a cartilage gap model. Journal of Tissue Engineering and Regenerative Medicine 4, 25-29Google Scholar
146Miller, R.E. et al. (2010) Effect of self-assembling peptide, chondrogenic factors, and bone marrow-derived stromal cells on osteochondral repair. Osteoarthritis Cartilage 18, 1608-1619CrossRefGoogle ScholarPubMed
Figure 0

Figure 1. AFM images of d-EAK16 peptide nanofibres in different assembling environment: (a) d-EAK16 peptide solution is incubated at 25°C for 4 h and then PBS is added for self-assembling overnight (left). d-EAK16 peptide solution is incubated at 100°C for 4 h and PBS is added for self-assembling overnight (middle). d-EAK16 peptide solution is incubated at 100°C for 4 h and PBS is added to stimulate self-assembly for two nights (right). (b) d-EAK16 peptides (100 µm) are displayed under different pH conditions. At pH 1, globular structures are formed (left). At pH 7, nanofibres are formed (middle). At pH 10.6, both globular structures and nanofibres are formed (right). (c) d-EAK16 peptides (1 mg/ml, 0.1%) are incubated with different denaturation agents: 1% SDS (left), 8.1 m urea (middle) and 7.1 m Guanidine.HCl (right) (Ref. 105). Adapted and reprinted with permission from (Ref. 105).

Figure 1

Table 1. The members of self-assembling ionic-complementary peptides (Refs 102, 103, 104, 105).

Figure 2

Figure 2. Various peptides-formed nanofibre structures: (a) molecular model of an IKVAV-containing PA, their self-assembly into nanofibres, as well as scanning electron microscopy (SEM) image of IKVAV nanofibres after adding cell media (DMEM) to PA aqueous solution (Ref. 41). (b) Q11 peptides are stimulated to self-assemble by the addition of salts, pH change, or the passage of time, and consequently they result in self-assembled matrix. Quick-freeze deep etch (QFDE) TEM images shows that Q11 peptides are assembled into a highly entangled network with fibrils of ~20 nm in diameter and ~100 nm between entanglement points (Ref. 50). (c) Chemical structure Fmoc-FF dipeptide and Cryo-SEM image of Fmoc-FF/K (1:1) nanofibrous hydrogel (Ref. 113). Adapted and reprinted with permission from (Refs 41, 50, 113).

Figure 3

Figure 3. Schematic illustration of two important approaches to design self-assembling peptide nanofibre scaffolds: there have been many self-assembling peptide sequences that can be modified with functional motifs (e.g. RGD and IKVAV). These self-assembling peptides have the ability to form stable 3D nanofibre structures with functional motifs. The density of these motifs can be changed through mixing self-assembling peptides and peptides with functional motifs in different ratios. In addition, it is feasible to store, retain and release various signal molecules (e.g. growth factors) within such 3D nanofibre scaffolds. These released growth factors and functional motifs can significantly induce cell function and tissue regeneration via binding to their corresponding receptors.

Figure 4

Figure 4. Promotion to cell culture in vitro: chondrocytes seeded on FEFEFKFK peptide nanofiber scaffolds contribute to good cell viability as demonstrated by (a) confocal microscopy z-stack image viewed along the z-axis (viable cells in green and the nuclei of dead cells in red) and cell morphology retention as demonstrated by (b) optical microscopy image showing the classic rounded morphology of chondrocytes in the gel matrix after 25 days culture and by (c) environmental scanning electron microscopy (ESEM) micrograph displaying a single-cell attached to the gel (Ref. 136). BMSCs cultured in RAD16-I peptide scaffolds result in extensive ECM production, as evidenced by (d) toluidine blue staining for sulphated GAG, immunohistochemistry images of (e) collagen type II and (f) type I (Ref. 33). Sustained release of TGF-β1 from KLDL12 peptide hydrogels comprising BM-MSCs is beneficial to the extensive accumulation of (g) proteoglycan identified by toluidine blue staining and (h) type II collagen identified by immunohistochemical staining (Ref. 34). (i) Chondrocyte-seeded KLDL12 peptide hydrogels substantially facilitate proteoglycan synthesis as showed by toluidine blue staining after 39 days of alternate day dynamic compression (Ref. 144). Adapted and reprinted with permission from (Refs 33, 34, 136, 144).

Figure 5

Figure 5. Promotion to cartilage regeneration in vivo: Alcian blue–eosin stained sections of the interface between the inner core and outer ring articular cartilage components at culture day 21, (a) RADA16-I hydrogel containing both TGF-β3 and chondrocytes showing robust cartilage formation in intimate contact with the native cartilage components compared to the treatment of (b) hydrogel-containing chondrocytes only (Ref. 145). Articular cartilage defects after 12 weeks postop treated with 10%TGFBPA + 100 ng/ml TGF-β1 (100TGF), showed by macroscopic views (c), histological evaluation of sample sections: (d) safranin-O staining for GAGs and (e) type II collagen staining (Ref. 35). Adapted and reprinted with permission from (Refs 35, 145).